ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
GlaxoSmithKline has reversed its decision to close a plant near Oak Hill, N.Y., that manufactures dermatology products, a move that would have eliminated the 260 jobs at the site. Instead, GSK says it will close its Clifton, N.J., oral care products facility and move the oral care manufacturing to Oak Hill. This will eliminate about 270 jobs in New Jersey. The initial plan to close Oak Hill followed the company's decision last year to move dermatological product manufacturing to Mississauga, Ontario. When the changes are complete, the Oak Hill facility will employ 211 workers.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter